Benzofuranyl derivatives used as glucokinase inhibitors

Details for Australian Patent Application No. 2010222589 (hide)

Owner Pfizer Inc.

Inventors Ling, Anthony Lai; Pfefferkorn, Jeffrey Allen

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-B-2010222589

PCT Pub. Number WO2010/103437

Priority 61/159,099 11.03.09 US

Filing date 4 March 2010

Wipo publication date 16 September 2010

Acceptance publication date 16 August 2012

International Classifications

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/497

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 3/04 Drugs for disorders of the metabolism

A61P 3/10 Drugs for disorders of the metabolism

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/103437 Priority application(s): WO2010/103437

16 August 2012 Application Accepted

  Published as AU-B-2010222589

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010222598-Scraper for scraper chain conveyors

2010222586-A device for stretching an elastic ring